1. Those Who Cannot Remember the Past are Condemned to Repeat It

   • Daniel P. Raymond

   Thoracic Oncology 07 January 2020 Pages: 623 - 624

2. Doing Our Part to Mitigate the Opioid Crisis

   • Crystal Fancher
   • Alicia M. Terando

   Breast Oncology 18 December 2019 Pages: 625 - 626

3. Why Breast Cancer Risk Models Fail: The Case of Lobular Carcinoma In Situ

   • David M. Euhus

   Breast Oncology 27 September 2019 Pages: 627 - 629

4. Health-Related Quality of Life After Cytoreductive Surgery/HIPEC for Mucinous Appendiceal Cancer: Results of a Multicenter Randomized Trial Comparing Oxaliplatin and Mitomycin

   • Sandy Tun
   • Oliver S. Eng
   • Monica Malec

   Peritoneal Surface Malignancy 17 December 2019 Pages: 630 - 631

5. Can Prognosis Be Modified in Pancreatic Cancer?

   • Motaz Qadan
   • Carlos Fernandez-del Castillo

   Pancreatic Tumors 07 November 2019 Pages: 632 - 633

6. Margins in DFSP Reconsidered: Primum Non Nocere

   • Winan J. van Houdt

   Sarcoma 04 November 2019 Pages: 634 - 636

7. Outcomes for Patients with Residual Stage II/III Breast Cancer Following Neoadjuvant Chemotherapy (AFT-01)

   • T. J. Stankowski-Drengler
   • J. R. Schumacher
   • H. B. Neuman

   Health Services Research and Global Oncology 03 January 2020 Pages: 637 - 644

   

8. Multidisciplinary Teams Improve Gastric Cancer Treatment Efficiency at a Large Safety Net Hospital

   • Michelle Ju
   • Sam C. Wang
   • Matthew R. Porembka

   Health Services Research and Global Oncology 01 November 2019 Pages: 645 - 650

   

9. Clinicopathologic Characteristics of Oligometastases from Esophageal Cancer and Long-Term Outcomes of Resection

   • Yu Ohkura
   • Junichi Shindoh
   • Harushi Udagawa

   Thoracic Oncology 02 January 2020 Pages: 651 - 659

   

10. ASO Author Reflections: Effectiveness of Resection of Oligometastases from Esophageal Cancer

    • Yu Ohkura

    ASO Author Reflections 06 January 2020 Pages: 660 - 661

11. Utility of Radiation After Neoadjuvant Chemotherapy for Surgically Resectable Esophageal Cancer

    • Francis I. Macedo
    • Jose Wilson Mesquita-Neto
    • Dido Franceschi

    Thoracic Oncology 01 December 2019 Pages: 662 - 670

    

12. Is There a Role for Surgery in Patients with Neuroendocrine Tumors of the Esophagus? A Contemporary View from the NCDB

    • Suna Erdem
    • Esther Troxler
    • Beat Gloor

    Thoracic Oncology 11 October 2019 Pages: 671 - 680

    

13. ASO Author Reflections: Surgical Resection of Esophageal Neuroendocrine Tumors Should Be Considered as an Integral Part of Multimodal Therapy in Localized Disease

    • Suna Erdem
    • Mathias Worni

    ASO Author Reflections 18 November 2019 Pages: 681 - 682

14. Tooth Loss Predicts Long-Term Prognosis of Esophageal Cancer After Esophagectomy

    • Susumu Miura
    • Tetsu Nakamura
    • Yoshihiro Kakeji

    Thoracic Oncology 11 October 2019 Pages: 683 - 690

    

15. ASO Author Reflections: Minimally Invasive Esophagectomy for Esophageal Cancer in the Prone and Lateral Position

    • Susumu Miura
    • Yoshihiro Kakeji

    ASO Author Reflections 29 October 2019 Pages: 691 - 691

16. Impact of Lymphadenectomy on Survival After Unimodality Transthoracic Esophagectomy for Adenocarcinoma of Esophagus

    • A. W. Phillips
    • K. Hardy
    • S. M. Griffin

    Thoracic Oncology 11 October 2019 Pages: 692 - 700

    

17. ASO Author Reflections: Lymphadenectomy in Esophagectomy: Why Bother?

    • Alexander W. Phillips
    • Sivesh K. Kamarajah

    ASO Author Reflections 25 October 2019 Pages: 701 - 702

18. Propensity-Matched Analysis Comparing Survival After Sublobar Resection and Lobectomy for cT1N0 Lung Adenocarcinoma

    • Xu-Heng Chiang
    • Hsao-Hsun Hsu
    • Jin-Shing Chen

    Thoracic Oncology 23 October 2019 Pages: 703 - 715

    

19. ASO Author Reflections: Sublobar Resection En Route to Becoming the Standard of Care for cT1N0 Lung Adenocarcinoma

    • Mong-Wei Lin
    • Jin-Shing Chen

    ASO Author Reflections 30 October 2019 Pages: 716 - 717

20. Surgical and Surgeon-Related Factors Related to Long-Term Survival in Esophageal Cancer: A Review

    • Sheraz R. Markar
    • Jesper Lagergren

    Thoracic Oncology Open access 05 November 2019 Pages: 718 - 723

21. The Landmark Series: Axillary Management in Breast Cancer

    • Carla S. Fisher
    • Julie A. Margenthaler
    • Theresa Schwartz

    Breast Oncology 20 December 2019 Pages: 724 - 729

22. Opioid Use after Breast-Conserving Surgery: Prospective Evaluation of Risk Factors for High Opioid Use

    • Ko Un Park
    • Kristin Kyrish
    • Sarah M. DeSnyder

    Breast Oncology 09 December 2019 Pages: 730 - 735

    

23. The Tyrer–Cuzick Model Inaccurately Predicts Invasive Breast Cancer Risk in Women With LCIS

    • Monica G. Valero
    • Emily C. Zabor
    • Melissa L. Pilewskie

    Breast Oncology 26 September 2019 Pages: 736 - 740

    

24. ASO Author Reflections: Breast Cancer Risk Assessment in Women with LCIS—More Work Is Needed

    • Monica G. Valero
    • Tari A. King
    • Melissa L. Pilewskie

    ASO Author Reflections 20 December 2019 Pages: 741 - 742

25. Contralateral Prophylactic Mastectomy Use After Neoadjuvant Chemotherapy

    • Nicole Christian
    • Emily C. Zabor
    • Mary L. Gemignani

    Breast Oncology 15 November 2019 Pages: 743 - 749

    

26. ASO Author Reflections: Neoadjuvant Chemotherapy for Breast Cancer May Not Alter Increasing Trends for CPM Utilization

    • Nicole Christian
    • Mary L. Gemignani

    ASO Author Reflections 14 November 2019 Pages: 750 - 751

27. Local Failure After Accelerated Partial Breast Irradiation with Intraoperative Radiotherapy with Electrons: An Insight into Management and Outcome from an Italian Multicentric Study

    • Maria Cristina Leonardi
    • Luigi Tomio
    • the Study Groups “Brachytherapy, Interventional Radiotherapy and Intraoperative Radiotherapy” and “Reirradiation” of the Italian Radiotherapy and Clinical Oncology Society (AIRO)

    Breast Oncology 15 November 2019 Pages: 752 - 762

    

28. ASO Author Reflections: Repeat Quadrantectomy and Re-irradiation Is Safe and Effective Treatment for Local Recurrence After Partial Breast Irradiation

    • Maria Cristina Leonardi

    ASO Author Reflections 17 December 2019 Pages: 763 - 764

29. Evaluation of the 12-Gene Molecular Score and the 21-Gene Recurrence Score as Predictors of Response to Neo-adjuvant Chemotherapy in Estrogen Receptor-Positive, HER2-Negative Breast Cancer

    • Hatem Soliman
    • Susanne Wagner
    • William Gradishar

    Breast Oncology Open access 06 January 2020 Pages: 765 - 771

    

30. Health-Related Quality of Life After Cytoreductive Surgery/HIPEC for Mucinous Appendiceal Cancer: Results of a Multicenter Randomized Trial Comparing Oxaliplatin and Mitomycin

    • Omeed Moaven
    • Konstantinos I. Votanopoulos
    • Edward A. Levine

    Peritoneal Surface Malignancy 12 November 2019 Pages: 772 - 780

    

31. ASO Author Reflections: Patient-Reported Outcomes of Mucinous Appendiceal Cancer Improve with Oxaliplatin HIPEC

    • Omeed Moaven
    • Kathleen C. Perry
    • Edward A. Levine

    ASO Author Reflections 12 November 2019 Pages: 781 - 782

32. Predictors of Anastomotic Failure After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Does Technique Matter?

    • Jason T. Wiseman
    • Charles Kimbrough
    • Jordan M. Cloyd

    Peritoneal Surface Malignancy 28 October 2019 Pages: 783 - 792

    

33. ASO Author Reflections: Impact of Operative Technique on Anastomotic Failure During Cytoreductive Surgery for Peritoneal Malignancies—Surgeon Preference is Fine

    • Jason T. Wiseman
    • Jordan M. Cloyd

    ASO Author Reflections 05 November 2019 Pages: 793 - 794

34. The Suggestion of Revised Criteria for Endoscopic Resection of Differentiated-Type Submucosal Gastric Cancer

    • Dae Won Ma
    • Seok Joo Lee
    • Jie-Hyun Kim

    Peritoneal Surface Malignancy 11 December 2019 Pages: 795 - 801

    

35. Long-Term Survival after Minimally Invasive Versus Open Gastrectomy for Gastric Adenocarcinoma: A Propensity Score-Matched Analysis of Patients in the United States and China

    • Jun Lu
    • Changhwan Yoon
    • Sam S. Yoon

    Gastrointestinal Oncology 01 January 2020 Pages: 802 - 811

    

36. Feasibility and Safety of Early Oral Intake and Discharge After Total or Proximal Gastrectomy: An Analysis of Consecutive Cases Without Exclusion Criteria

    • Masatoshi Nakagawa
    • Masanori Tokunaga
    • Yusuke Kinugasa

    Gastrointestinal Oncology 13 November 2019 Pages: 812 - 821

    

37. ASO Author Reflections: Feasibility and Safety of Early Oral Intake and Discharge After Total or Proximal Gastrectomy: An Analysis of Consecutive Cases Without Exclusion Criteria

    • Masatoshi Nakagawa

    ASO Author Reflections 06 January 2020 Pages: 822 - 823

38. Technique for Robotic Ivor Lewis Esophagectomy with 6-cm Linear Stapled Side-to-Side Anastomosis

    • June S. Peng
    • Steven J. Nurkin
    • Moshim Kukar

    Gastrointestinal Oncology 04 December 2019 Pages: 824 - 824

39. Utilization of Adjuvant Radiotherapy for Resected Colon Cancer and Its Effect on Outcome

    • Rodney E. Wegner
    • Stephen Abel
    • Alexander V. Kirichenko

    Colorectal Cancer 12 November 2019 Pages: 825 - 832

    

40. Perioperative Blood Transfusion is Associated with Postoperative Systemic Inflammatory Response and Poorer Outcomes Following Surgery for Colorectal Cancer

    • Stephen T. McSorley
    • Alexander Tham
    • Donald C. McMillan

    Colorectal Cancer Open access 29 October 2019 Pages: 833 - 843

    

41. Comprehensive Comparative Analysis of Prognostic Value of Systemic Inflammatory Biomarkers for Patients with Stage II/III Colon Cancer

    • Shinsuke Suzuki
    • Takashi Akiyoshi
    • Masashi Ueno

    Colorectal Cancer 12 November 2019 Pages: 844 - 852

    

42. ASO Author Reflections: Comparison of Prognostic Impact of Various Systemic Inflammatory Markers for Stage II/III Colon Cancer

    • Shinsuke Suzuki
    • Takashi Akiyoshi

    ASO Author Reflections 12 November 2019 Pages: 853 - 854

43. Grade is a Dominant Risk Factor for Metastasis in Patients with Rectal Neuroendocrine Tumors

    • Ian W. Folkert
    • Andrew J. Sinnamon
    • Robert E. Roses

    Endocrine Tumors 07 November 2019 Pages: 855 - 863

    

44. ASO Author Reflections: Revisiting Risk of Dissemination from Small Rectal Neuroendocrine Tumors

    • Ian W. Folkert
    • Robert E. Roses

    ASO Author Reflections 20 November 2019 Pages: 864 - 865

45. Utilizing Machine Learning for Pre- and Postoperative Assessment of Patients Undergoing Resection for BCLC-0, A and B Hepatocellular Carcinoma: Implications for Resection Beyond the BCLC Guidelines

    • Diamantis I. Tsilimigras
    • Rittal Mehta
    • Timothy M. Pawlik

    Hepatobiliary Tumors 06 November 2019 Pages: 866 - 874

    

46. ASO Author Reflections: Resection for Hepatocellular Carcinoma Beyond the BCLC Guidelines—How Can Machine Learning Techniques Help?

    • Diamantis I. Tsilimigras
    • Timothy M. Pawlik

    ASO Author Reflections 04 November 2019 Pages: 875 - 876

47. Fong’s Score in the Era of Modern Perioperative Chemotherapy for Metastatic Colorectal Cancer: A Post Hoc Analysis of the GERCOR-MIROX Phase III Trial

    • Samira Makhloufi
    • Anthony Turpin
    • Mohamed Hebbar

    Hepatobiliary Tumors 22 October 2019 Pages: 877 - 885

    

48. ASO Author Reflections: Fong’s Score in the Era of Modern Strategies for Metastatic Colorectal Cancer

    • Anthony Turpin
    • Mohamed Hebbar

    ASO Author Reflections 12 November 2019 Pages: 886 - 886

49. Clinical Implications of Naples Prognostic Score in Patients with Resected Pancreatic Cancer

    • Nobuhiko Nakagawa
    • Suguru Yamada
    • Yasuhiro Kodera

    Pancreatic Tumors 17 December 2019 Pages: 887 - 895

    

50. ASO Author Reflections: The Naples Prognostic Score Predicts Long-Term Survival in Patients with Resected Pancreatic Cancer

    • Nobuhiko Nakagawa
    • Suguru Yamada
    • Yasuhiro Kodera

    ASO Author Reflections 17 December 2019 Pages: 896 - 897